eP213: Phase 2 multiple ascending-dose study of SRP-5051 PPMO in patients with DMD amenable to exon 51 skipping: Part A resultsCraig Campbell, H. Phan, Katherine D. Mathews et al.|Genetics in Medicine|2022Cited by 2
Utrophin modulators to treat Duchenne muscular dystrophy (DMD): Phase 1b Clinical Trial Results of SMT C1100 (P2.006)Jon Tinsley, Kay E. Davies, Imelda Hughes et al.|Neurology|2015Cited by 1